EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Guideline-concordance along the cancer care continuum and breast cancer mortality by race and ethnicity: a SEER-Medicare study

Emma L Herbach, Ryan M Carnahan, Lauren E McCullough, Bradley D McDowell, Michaela Curran, Kai Wang, Ingrid M Lizarraga, Mary E Charlton, Sarah H Nash

Cancer Causes & Control · 2026

DOI: 10.1007/s10552-025-02099-9 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Cancer Causes & Control, 2026. Verfasst von Emma L Herbach und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, USA. eherbach@miami.edu. Hauptthemen laut MEDLINE: Breast Neoplasms, Ethnicity, Guideline Adherence, Continuity of Patient Care. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCCDPHP CDC HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To examine the relationship between guideline-concordant breast cancer care and hazard of cancer death by patient race and ethnicity.

Methods

We used SEER-Medicare data to identify 212,555 older women diagnosed with invasive breast cancer between 2000 and 2017. Guideline-concordant diagnostic workup, locoregional treatment, and initiation of systemic therapy were defined using NCCN guidelines. Hazards of breast cancer death 2 and 5 years from diagnosis by each guideline-concordance outcome overall and stratified by race and ethnicity were estimated using Cox proportional hazards models.

Results

Non-concordant diagnostic workup, locoregional treatment, and systemic therapy initiation were each associated with increased hazards of 2- and 5-year breast cancer mortality (diagnostics HR 2-year (95% CI) 1.33 (1.25–1.41), HR 5-year 1.29 (1.23–1.35); locoregional HR 2-year 2.10 (1.98–2.23), HR 5-year 1.83 (1.76–1.90); systemics HR 2-year 1.67 (1.51–1.84), HR 5-year 1.56 (1.45–1.68)). Non-concordant diagnostic workup and systemic therapy initiation were associated with greater hazard of 2- and 5-year breast cancer death among Black, Asian/Pacific Islander, Hispanic White, and non-Hispanic White patients; there was no consistent association among American Indian/Alaska Native patients for either outcome. Locoregional treatment was strongly associated with hazards of cancer death for all groups.

Conclusion

Equitable delivery of guideline-recommended breast cancer care from diagnosis through treatment across racial and ethnic groups may mitigate survival disparities. Efforts to improve access to high-quality care must be informed by and responsive to the social and structural root causes of health inequities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEthnicityGuideline AdherenceContinuity of Patient CareHumansFemaleAgedMedicareSEER ProgramUnited StatesAged, 80 and overPractice Guidelines as TopicHealthcare DisparitiesRacial Groups

Stichwörter der Autor:innen

Breast cancerGuideline-concordant careRacial disparitiesSurvival

Autor:innen und Institutionen

  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, USA. eherbach@miami.edu.
  • Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. eherbach@miami.edu.
  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, USA.
  • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • University of Iowa Holden Comprehensive Cancer Center, Iowa City, IA, USA.
  • Department of Community and Behavioral Health, College of Public Health, University of Iowa, Iowa City, IA, USA.

Förderung

  • NCI NIH HHS
  • NCCDPHP CDC HHS
  • National Cancer Institute

Zitieren

APA

Herbach, E. L., Carnahan, R. M., McCullough, L. E., McDowell, B. D., Curran, M., Wang, K., Lizarraga, I. M., Charlton, M. E., & Nash, S. H. (2026). Guideline-concordance along the cancer care continuum and breast cancer mortality by race and ethnicity: a SEER-Medicare study. Cancer Causes & Control. https://doi.org/10.1007/s10552-025-02099-9

Vancouver

Herbach EL, Carnahan RM, McCullough LE, McDowell BD, Curran M, Wang K, et al. Guideline-concordance along the cancer care continuum and breast cancer mortality by race and ethnicity: a SEER-Medicare study. Cancer Causes & Control. 2026. doi:10.1007/s10552-025-02099-9

BibTeX
@article{Herbach2026,
  author = {Herbach, Emma L and Carnahan, Ryan M and McCullough, Lauren E and McDowell, Bradley D and Curran, Michaela and Wang, Kai and Lizarraga, Ingrid M and Charlton, Mary E and Nash, Sarah H},
  title = {Guideline-concordance along the cancer care continuum and breast cancer mortality by race and ethnicity: a SEER-Medicare study},
  journal = {Cancer Causes & Control},
  year = {2026},
  doi = {10.1007/s10552-025-02099-9}
}
Kostenlos starten →